31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
Early this year, the Social Security Administration (SSA) resumed the mailing of “No-Match” letter...
Read More >
A key tool in mitigating the risks due to unforeseen events is the force majeure clause contained in...
Read More >
On Friday, December 6, 2019, a coalition of national and state trade associations filed suit in Cali...
Read More >
On June 19, 2019, the New York State Legislature passed Senate Bill S.6577, which upon Governor Cuom...
Read More >
In a split decision, the National Labor Relations Board (NLRB or the Board) ruled last week that a p...
Read More >
USCIS released a message that employers for now should continue to use the current Form I-9 for empl...
Read More >